Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-061177

Chief Commercial Officer acquired 7,838 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-30 Grant or award : show line 1 in the form +7,838 $1.45 $11,326 358,722 D
Loading xslF345X03/doc4.xml…